MedTrace Logo

Longitudinal Cohort Study on ICH Care

NCT03183167 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1076

Last updated 2017-06-09

No results posted yet for this study

Summary

Intracerebral hemorrhage \[ICH\] is the most feared sub-type of stroke, associated with a high mortality rate up to 50% and thus leaving large proportions of patients in functionally dependent states. In recent years randomized trials have failed to provide an effective intervention to improve functional outcome in ICH. Therefore, evidence regarding acute therapeutic interventions as well as secondary treatment approaches is still limited.

The present monocentric longitudinal study on spontaneous ICH patients is based on a prospective institutional stroke registry including all hemorrhagic stroke patients treated at a German University Hospital, Department of Neurology, over a 10 year time frame (2006-2015). The main aim of this investigation, besides analyses of epidemiological aspects, will be (i) to identify possible treatment targets influencing functional outcome, and (ii) to evaluate existing therapeutic strategies in ICH care.

Conditions

  • Spontaneous Intracerebral Hemorrhage

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Hagen B. Huttner, MD. PhD. · University Hospital Erlangen, Department of Neurology, Germany

  • Joji B. Kuramatsu, MD. · University Hospital Erlangen, Department of Neurology, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-01
Primary Completion
2016-12-31
Completion
2017-04-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03183167 on ClinicalTrials.gov